Unveiling the adverse events of Nusinersen in spinal muscular atrophy management based on FAERS database [PDF]
Ying Jiang +3 more
openalex +1 more source
Functional and structural analysis of SITTER patients with spinal muscular atrophy. [PDF]
Bieniaszewska A, Sobieska M, Gajewska E.
europepmc +1 more source
Eosinophilic Esophagitis in a 3-Year-Old Girl with Spinal Muscular Atrophy Type 1: The First Reported Case. [PDF]
Marzec A +2 more
europepmc +1 more source
Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients. [PDF]
Zandl-Lang M +10 more
europepmc +1 more source
Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy. [PDF]
Hassan A +16 more
europepmc +1 more source
Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center Experience. [PDF]
Bekircan-Kurt CE +16 more
europepmc +1 more source
Nusinersen Initiation After Onset of Weakness Does Not Prevent Progression of Hip Instability
Evelyn Kuong +6 more
openalex +1 more source

